Article
Promoter Hypermethylation in Prostate Cancer
1 Oct 2010
Abstract excerpt
BACKGROUND: The prostate gland is the most common site of cancer and the second leading cause of cancer mortality in American men. It is well known that epigenetic alterations such as DNA methylation within the regulatory (promoter) regions of genes are associated with transcriptional silencing in cancer. Promoter hypermethylation of critical pathway genes could be potential biomarkers and therapeutic targets for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
